Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Corvus Pharmaceuticals Inc. (CRVS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 1,890,507 $16,221 1.42%
2.
OrbiMed Advisors

Samuel Isaly

5,967,584 $51,202 0.61%
3.
EcoR1 Capital

Oleg Nodelman

351,401 $3,015 -22% 0.27%
4.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

575,000 $4,934 0.17%
5.
Sectoral Asset Management

Jerome Pfund And Michael Sjostrom

12,594 $108 0.01%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.99 5,000 Officer, Director 1,118,795 2018-12-06 Filing
$5.95 1,502 Officer, Director 1,113,795 2018-12-04 Filing
$8.50 588,235 Large Shareholder, Director 5,967,584 2018-03-12 Filing
$8.50 588,235 Large Shareholder, Director 5,967,584 2018-03-12 Filing
$8.50 1,176,470 Large Shareholder 4,420,516 2018-03-12 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 3,275,616 $28,105 4.42%
2. 4,420,516 $37,928 3.02%
3. 588,706 $5,051 0.46%
4. 108,000 $710 0.33%
5. 321,430 $2,758 0.31%